Luteinizing Hormone Receptor Mutations in Disorders of Sexual Development and Cancer

References

• Dufau M L. The luteinizing hormone receptor. The Leydig Cell, A H Payne, M P Hardy, L D. Russell. Cache River Press, IL 1996; 333–350
   Google Scholar
• Iismaa T P, Biden T J, Shine J. G. Protein-Coupled Receptors. R.G. Landes, Co., TX 1995
   Google Scholar
• Probost W C, Snyder L A, Schuster D I, Brosius J, Sealfon S C. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 1992; 11: 1–20
   Google Scholar
• Cooke B A. Transduction of the luteinizing hormone signal within the Leydig cell. The Leydig Cell, A H Payne, M P Hardy, L D. Russell. Cache River Press, IL 1996; 351–363
   Google Scholar
• Waterman M R. Production of sex steroids. Sex Differentiation: Clinical and Biological Aspects. Frontiers in Endocrinology. Serono Symposia, RomeItaly. I A. Hughes. 1996; 61–69, Vol. 20
   Google Scholar
• Shenker A, Laue L, Kosugi S, Merendino J J, Jr, Minegishi T, Cutler G B., Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993; 365: 652–654
   PubMed Web of Science ®Google Scholar
• Dahia P LM, Toledo S PA. Peptide hormone receptor defects leading to abnormal phenotypes. Curr Opin Endocrinol Diab 1996; 3: 132–137
   Google Scholar
• Conway G S. Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol 1996; 45: 657–663
   PubMed Web of Science ®Google Scholar
• Thernmen A PN, Brunner H G. Luteinizing hormone receptor mutations and sex differentiation. Eur J Endocrinol 1996; 134: 533–540
   Google Scholar
• Themmen A PN, Martens J WM, Brunner H G. Gonadotropin receptor mutations. J Endocrinol 1997; 153: 179–183
   PubMed Web of Science ®Google Scholar
• DiMeglio L A, Pescovitz O H. Disorder of puberty: Inactivating and activating molecular mutations. J Pediatr 1997; 131: S8–12
   Google Scholar
• Chan W Y, Cutler G B., Jr. Mutations of gonadotrophin receptors leading to loss and gain of function. Top Endocrinol 1998; 8: 9–12
   Google Scholar
• Shenker A. Disorders caused by mutations of the lutropin/choriogonadotropin receptor gene. Contemporary Endocrinology: G Proteins, Receptors, and Disease, A M. Spiegel. Humana Press Inc., NJ 1998; 139–152
   Google Scholar
• Chan W Y, Cutler G B., Jr. Molecular aspects of precocious puberty. Adv Mol Cell Endocrinol 1998; 2: 121–141
   Google Scholar
• Chan W Y. Molecular genetics, biochemical and clinical implications of gonadotropin receptor mutations. Mol Genet Metab 1998; 63: 75–84
   Google Scholar
• Latronico A C, Segaloff D L. Naturally occurring mutations of the luteinizinghormone receptor: Lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet 1999; 65: 949–958
   PubMed Web of Science ®Google Scholar
• Schedewie H K, Reiter E O, Beitins I Z, Seyed S, Wooten V D, Jimenez J F, Aiman E, de Vane G W, Redman J F, Elders J M. Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab 1981; 52: 271–278
   PubMed Web of Science ®Google Scholar
• Rosenthal S M, Grumbach M M, Kaplan S L. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): Effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab 1983; 57: 571–579
   PubMed Web of Science ®Google Scholar
• Bertelloni S, Baroncelli G I, Lala R, Cappa M, Matarazzo P, de Sanctis C, Saggese G. Long-term outcome of male-limited gonadotropin-independent precocious puberty. Horm Res 1998; 48: 235–239
   Google Scholar
• Praksasam G, Castro-Magana M, Arguello R, Angulo M, Canas A, Kam R, Vitollo P, Chan W Y. Hormonal profile during treatment in familial male-limited precocious puberty due to a novel heteroxygous activating mutation of the LH receptor. Program and Abstract. The 80th Annual Meeting of the Endocrine Society. 1998; 283
   Google Scholar
• Gromoll J, Partsch C J, Simoni M, Nordhoff V, Sippell W G, Nieschlag E, Saxena B B. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab 1998; 83: 476–480
   PubMed Web of Science ®Google Scholar
• Müller J, Gondos B, Kosugi S, Mori T, Shenker A. Severe testotoxicosis phenotype associated with Asp578-Tyr mutation of the lutrophin/choriogonadotrophin receptor gene. J Med Genet 1998; 35: 340–341
   PubMed Web of Science ®Google Scholar
• Latronico A C, Abell A N, Arnhold I JP, Liu X, Lins T SS, Brito V N, Billerbeck A E, Segaloff D L, Mendonca B B. A unqiue constitutively activating mutation in third transmembrane helix of the luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 1998; 83: 2435–2440
   PubMed Web of Science ®Google Scholar
• Wu S M, Leschek E W, Brain C, Chan W Y. A novel activating mutation of the luteinizing hormone/chorionic gonadotropin receptor in a patient with FMPP—Effects of size versus charge. Mol Genet Metab 1999; 66: 68–73
   PubMed Web of Science ®Google Scholar
• Kremer H, Martens J WM, van Reen M, Verhoef-Post M, Wit J M, Otten B J, Drop S LS, Delemarre-van de Waal H A, Pombo-Arias M, De Luca F, Potau N, Buckler J MH, Jansen M, Parks J S, Latif H A, Moll G W, Epping W, Saggese G, Mariman E CM, Themmen A PN, Brunner H G. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male-limited precocious puberty. J Clin Endocrinol Metab 1999; 84: 1136–1140
   PubMed Web of Science ®Google Scholar
• Latronico A C, Brito V N, Lins T S, Arnhold I JP, Mendonca B B. Effects of three distinct activating mutations of the luteinizing hormone receptor (LHR) on pituitary-gonadal axis in both sexes. Program and Abstracts. The 81th Annual Meeting of the Endocrine Society. 1999; 310
   Google Scholar
• Laue L, Wu S M, Kudo M, Hsueh A JW, Cutler G B, Jr, Jelly D H, Diamond F B, Chan W Y. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty. Biochem Mol Med 1996; 58: 192–198
   PubMedGoogle Scholar
• Pollack M R, Brown E M, Estep H L, McLaine P N, Kifor O, Park J, Hebert S C, Seidman C E, Seidman J G. Autosomal dominant hypocalcaemia caused by a Ca2+ -sensing receptor gene mutation. Nat Genet 1994; 8: 303–307
   PubMed Web of Science ®Google Scholar
• Baron J, Winer K K, Yanovski J A, Cunningham A W, Laue L, Zimmerman D, Cutler G B., Jr. Mutations in the Ca2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996; 5: 601–606
   Google Scholar
• Duprez L, Parma J, Costagliola S, Hermans J, van Sande J, Dumont J E, Vassart G. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 1997; 409: 469–474
   Google Scholar
• Huang J, Puett D. Identification of two amino acid residues on the extracellular domain of the lutropin/choriogonadotropin receptor important in signaling. J Biol Chem 1995; 270: 30023–30028
   Google Scholar
• Alvarez C A, Narayan P, Huang J, Puett D. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix I that is important in ligand-mediated signaling. Endocrinology 1999; 140: 1775–1782
   Google Scholar
• Abell A N, Segaloff D L. Evidence for the direct involvement of transmembrane region 6 of the lutropin/choriogonadotropin receptor in activating Gs. J Biol Chem 1997; 272: 14586–14591
   Google Scholar
• Abell A N, McCormick D J, Segaloff D L. Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs. Mol Endocrinol 1998; 12: 1857–1869
   Google Scholar
• Kudo M, Osuga Y, Kobilka B K, Hsueh A JW. Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J Biol Chem 1996; 271: 22470–22478
   Google Scholar
• Kosugi S, Lin Z, Pearlstein R, Mori T, Shenker A. Evidence that interhelical hydrogen bonding between Asp-578 and Asn 619 helps maintain the inactive conformation of the human lutropin receptor (LHR). Program and Abstracts. The 79th Annual Meeting of the Endocrine Society. 1997; 171
   Google Scholar
• Kosugi S, Mori T, Shenker A. The role of Asp578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J Biol Chem 1996; 271: 31813–31817
   Google Scholar
• Wess J. G-protein-coupled receptors. Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 1997; 11: 346–354
   PubMed Web of Science ®Google Scholar
• Kosugi S, Mori T, Shenker A. An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/ choriogonadotropin receptor. Mol Pharmacol 1998; 53: 894–901
   Google Scholar
• Yano Y, Saji M, Hidaka A, Moriya N, Okuno A, Kohn L D, Cutler G B., Jr. A new constitutively activating point mutation in the luteinizing hormone/ chorionic gonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab 1995; 80: 1162–1168
   PubMed Web of Science ®Google Scholar
• Kosugi S, Van Dop C, Geffner M E, Rabl W, Card J C, Chaussain J L, Mori T, Merendino J J, Shenker A. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet 1995; 4: 183–188
   PubMed Web of Science ®Google Scholar
• Yano Y, Hidaka A, Saji M, Polymeropoulos A, Okuno A, Kohn L D, Cutler G B., Jr. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor as familial cases. J Clin Endocrinol Metab 1994; 79: 1818–1823
   PubMed Web of Science ®Google Scholar
• Cutler G B., Jr. Overview of premature sexual development. Sexual Precocity: Etiology, Diagnosis, and Management, G D Grave, G B. Cutler, Jr. Raven Press, NY 1993; 1–10
   Google Scholar
• Berttelloni S, Baroncelli G I, Lala R, Cappa M, Matarazzo P, de Samctos C, Saggese G. Long-term outcome of male-limited gonadotropin-independent precocious puberty. Horm Res 1997; 48: 235–239
   Google Scholar
• Holland F J. Gonadotropin-independent precocious puberty. Endocrinol Metab Clin North Amer 1991; 20: 191–210
   PubMed Web of Science ®Google Scholar
• Laue L, Cutler G B., Jr. Current treatment of familial male precocious puberty. Sexual Precocity: Etiology, Diagnosis, and Management, G D Grave, G B. Cutler, Jr. Raven Press, NY 1993; 193–205
   Google Scholar
• Rosenthal I M, Refetoff S, Rich B, Barnes R B, Sunthornthepvarakul T, Parma J, Rosenfield R L. Response to change with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor—a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3802–3806
   Google Scholar
• Grumbach M M, Styne D M. Puberty: Ontogeny, neuroendocrinology, physiology, and disorders. Williams Textbook of Endocrinology, 9th Edition., J D Wilson, D W Foster, H M Kronenberg, P R. Larsen. WD Saunders, NY 1998; 1509–1625
   Google Scholar
• Kletter G B, Kelch R P. Disorders of puberty in boys. Endocrinol Metab Clin North Amer 1993; 22: 455–477
   Google Scholar
• De Vane G W, Czekala N M, Judd H L, Yen S SC. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol 1975; 121: 496–500
   PubMed Web of Science ®Google Scholar
• Risma K A, Clay C M, Nett T M, Wagner T, Yun J, Nilson J H. Targeted over-expression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries and ovarian tumors. Proc Natl Acad Sci, USA 1995; 92: 1322–1326
   PubMed Web of Science ®Google Scholar
• Bogovich K. Prolonged stimulation of follicle-stimulating hormone is required for the induction of ovarian follicular cysts by human chorionic gonadotropin in hypophysectomized rats. Endocrine 1997; 4: 107–114
   Google Scholar
• Laue L. Ligand-independent hormone secretion. Curr Opin Pediatr 1995; 7: 434–439
   Google Scholar
• Weinstein L S, Shenker A. G protein mutations in human disease. Clin Biochem 1993; 26: 333–338
   Google Scholar
• van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. Genetic basis of endocrine disease. Somatic and germline mutations of the TSH receptor gene in thyroid disease. J Clin Endocrinol Metab 1995; 80: 2577–2585
   PubMed Web of Science ®Google Scholar
• Venturelli E, Coradini D, Gornati D, Secreto G. Growth stimulatory effect and metabolism of testosterone in MCF-7 human breast cancer cells. Internat J Oncol 1996; 8: 687–692
   PubMedGoogle Scholar
• Rajpert-De Meyts E, Skakkabaek N E. The possible role of sex hormones in the development of testicular cancer. Euro Urol 1993; 23: 54–59
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Jorgensen N, Muller J, Giwercman A, Skakkabaek N E. Origin of germ cell tumors. Sex Differentiation: Clinical and Biological Aspects, I A. Hughes. Frontiers in Endocrinology, Serono Symposia, Rome, Italy 1996; 20: 45–54
   Google Scholar
• Akre O, Ekbom A, Hsieh C C, Trichopoulos D, Adami H O. Testicular non-seminoma and seminoma in relation to perinatal characteristics. J Nat Canc Inst 1996; 88: 883–889
   PubMed Web of Science ®Google Scholar
• Rottger J, Hadden D R, Morrison E, McKeown F. Isosexual precocious puberty in a 9-year-old boy: nodular interstitial cell hyperplasia. J Royal Soc Med 1981; 74: 66–68
   Google Scholar
• Martin M M, Wu S M, Martin A LA, Rennert O M, Chan W Y. Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor. Euro J Endocrinol 1998; 139: 101–106
   PubMed Web of Science ®Google Scholar
• Liu G, Duranteau L, Monroe J, Doyle D A, Carel J C, Shenker A. A novel somatic mutation of the lutropin receptor (LHR) gene in Leydig cell adenoma. Program and Abstracts. The 80th Annual Meeting of the Endocrine Society. 1998; 61
   Google Scholar
• Laue L, Chan W Y, Hsueh A JW, Kudo M, Hsu S Y, Wu S M, Blomberg L A, Cutler G B., Jr. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male precocious puberty. Proc Natl Acad Sci USA 1995; 92: 1906–1910
   PubMed Web of Science ®Google Scholar
• Evans B AJ, Bowen D J, Smith P J, Clayton P E, Gregory J W. A new point mutation in the luteinizing hormone receptor gene in familial and sporadic male-limited precocious puberty: Genotype does not always correlate with phenotype. J Med Genet 1996; 33: 143–147
   PubMed Web of Science ®Google Scholar
• Oerter K E, Uriarte M, Rose S R, Barnes K M, Cutler G B., Jr. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab 1990; 71: 1251–1258
   PubMed Web of Science ®Google Scholar
• Clark P A, Clarke W L. Testotoxicosis: An unusual presentation and novel gene mutation. Clin Pediat 1995; 34: 271–274
   Google Scholar
• Saldanha P H, Arnhold I JP, Mendonça B B, Bloise W, Toledo S PA. A clinicogenetic investigation of Leydig cell hypoplasia. Am J Med Genet 1987; 26: 337–344
   Google Scholar
• Laue L, Wu S M, Kudo M, Hsueh A JW, Griffin J E, Wilson J D, Grant D B, Berry A C, Cutler G B, Jr, Chan W Y. (1994) The Gene defect that causes genetically XY males to develop as apparent females (Leydig cell hypoplasia). Selected Biomedical Research Summaries. ASCB Annual Meeting. Third Annual Press Book, American Society for Cell Biology, MD, 1994, 1
   Google Scholar
• Martens J WM, Verhoef-Post M, Abelin N, Ezabella M, Toledo S PA, Brunner H G, Themmen A PN. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 1998; 12: 775–784
   PubMedGoogle Scholar
• Lumbroso S, Szarras-Czapnik M, Caubel C, Rinegeard I, Romer T E, Sultan C. Novel compound heterozygous mutations of luteinizing hormone receptor gene in a patient with male pseudohermaphroditism due to Leydig cell hypoplasia. Program and Abstracts. The 80th Annual Meeting of the Endocrine Society. 1998; 283
   Google Scholar
• Wu S M, Hallermeier K, Laue L, Brain C, Berry E C, Grant D B, Griffin J E, Wilson J D, Cutler G B, Jr, Chan W Y. Inactivation of the luteinizing hormone/ chorionic gonadotropin receptor by an insertional mutation in Leydig Cell Hypoplasia. Mol Endocrinol 1998; 12: 1651–1660
   Google Scholar
• Arnhold I JP, Latronico A C, Batista M C, Mendonca B B. Menstrual disorders and infertility caused by inactivating mutations of the luteinizing hormone receptor gene. Fertil Steril 1999; 71: 597–601
   PubMed Web of Science ®Google Scholar
• Jia X C, Oikawa M, Bo M, Tanaka T, Ny T, Boime I, Hsueh A JW. Expression of human luteinizing hormone (LH) receptor: Interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species. Mol Endocrinol 1991; 5: 759–768
   PubMedGoogle Scholar
• Laue L, Wu S M, Kudo M, Bourdony C J, Cutler G B, Jr, Hsueh A JW, Chan W Y. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 1996; 10: 987–997
   PubMedGoogle Scholar
• McFarland K C, Sprengel R, Phillips H S, Kohler M, Rosemblit N, Nikolics K, Segaloff D L, Seeburg P H. Lutropin-chorionadotropin receptor: An unusual member of the G protein-coupled receptor family. Science 1989; 245: 494–499
   PubMed Web of Science ®Google Scholar
• Thomas D, Rozell T G, Liu X, Segaloff D L. Mutational analysis of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1–6 are involved in hormone binding. Mol Endocrinol 1996; 10: 760–768
   Google Scholar
• Latronico A C, Chai Y, Arnhold I JP, Liu X, Mendonca B B, Degaloff D L. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 1998; 12: 442–450
   Google Scholar
• Laue L, Wu S M, Kudo M, Hsueh A JW, Cutler G B, Jr, Griffin J E, Wilson J D, Brain C, Berry A C, Grant D B, Chan W Y. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 1995; 8: 1429–1433
   Google Scholar
• Misrahi M, Meduri G, Pissard S, Bouvattier C, Beau I, Loosfelt H, Jolivet A, Rappaport R, Milgrom E, Bougneres P. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 1997; 82: 2159–2165
   Google Scholar
• Stavrou S S, Zhu Y S, Cai L Q, Katz M D, Herrera C, DeFilio-Ricart M, Imperato-McGinley J. A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 1998; 83: 2091–2098
   Google Scholar
• Kawata N, Menon K MJ. Palmitoylation of luteinizing hormone/human choriogonadotropin receptors in transfected cells. J Biol Chem 1994; 269: 30651–30658
   Google Scholar
• Rodriguez M C, Xie Y B, Wang H, Collison K, Segaloff D L. Effects of truncations of cytoplasmic tail of the LH/CG receptor on receptor-mediated hormone internalization. Mol Endocrinol 1992; 6: 327–336
   Google Scholar
• Kremer H, Kraaij R, Toledo S PA, Post M, Fridman J P, Hayashida C Y, van Reen M, Milgrom E, Ropers H H, Mariman E, Themmen A PN, Brunner H G. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 1995; 9: 160–164
   PubMed Web of Science ®Google Scholar
• Latronico A C, Anasti J, Arnhold I JP, Rapaport R, Mendonca B B, Bloise W, Castro M, Tsigos C, Chrousos G P. Brief Report: Testicular and Ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. New Engl J Med 1996; 334: 507–512
   PubMed Web of Science ®Google Scholar
• Zajac J D, Warne G L. Disorders of sexual development. Bailliere's Clin Endocrinol Metab 1995; 9: 555–579
   Google Scholar
• Toledo S PA. Leydig cell hypoplasia leading to 2 different phenotypes: Male pseudohermaphroditism and primary hypogonadism not associated with this. Clin Endocrinol 1992; 36: 521–522
   PubMedGoogle Scholar
• Toledo S PA, Brunner H G, Kraaij R, Post M, Dahia P LM, Hayashida C Y, Kremer H, Themmen A PN. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX female. J Clin Endocrinol Metab 1996; 81: 3850–3864
   Google Scholar
• Toledo S PA. Inactivating mutations of the LH receptor gene: more than two different phenotypes. Eur J Endocrinol 1999; 140: 186
   Google Scholar